OFIX Stock Analysis: Buy, Sell, or Hold?
OFIX - Orthofix Medical Inc. Common Stock (DE)
$9.09
-0.12 (-1.30%)
âŧ
5d:
-3.71%
30d:
-3.09%
90d:
-21.43%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 03, 2026
30d
Get Alerted When OFIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: OFIX is fairly priced but lacks strong directional signals. At 6.7% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: OFIX is fairly priced but lacks strong directional signals. At 6.7% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.41
Based on -2.9% avg growth
INTRINSIC VALUE TODAY
$3.98
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OFIX is currently trading at $9.09, which is considered fair relative to its 30-day fair value range of $8.91 to $9.57. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.6) compared to its historical average (20.2). At these levels, the market is pricing in 6.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OFIX is in a downtrend. Immediate support is located at $8.57, while resistance sits at $9.94.
Market Sentiment: OFIX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.00 (+43.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OFIX is in a downtrend. Immediate support is located at $8.57, while resistance sits at $9.94.
Market Sentiment: OFIX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.00 (+43.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$8.91 -
$9.57
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
49.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 43.0% below Wall St target ($13.00)
- NEUTRAL: Trading at premium valuation - market expects 6.7% growth which is achievable
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.91 -
$9.57
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$8.57
Resistance Level
$9.94
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.57
Wall Street Target
$13.00
(+43.0%)
Revenue Growth (YoY)
3.8%
Profit Margin
-7.4%
Valuation Premium vs History
+6.7% premium
PE vs Historical
24.6 vs 20.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.7%
(market-implied from PE analysis)
1-Year Target
$9.70
(+7%)
2-Year Target
$10.35
(+14%)
3-Year Target
$11.04
(+22%)
3-Yr Target (if PE normalizes)
(PE: 25â20)
PE COMPRESSION
$9.08
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.6, Growth: -9.8%)
$6.68
(+-27%)
Base:
(SPY PE: 20.4, Growth: -9.8%)
$5.55
(-39%)
Bear:
(PE: 17.3, Growth: -9.8%)
$4.72
(-48%)
Share & Embed Analysis
Last updated: October 03, 2026 11:15 AM ET
Data refreshes hourly during market hours. Next update: 12:15 PM
Data refreshes hourly during market hours. Next update: 12:15 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OFIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jorge Andres Cedron
SELL
3743 shares
2026-04-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 38 SELL |
